# The claim that taking acetaminophen (Tylenol) during pregnancy causes autism in children is not supported by the strongest available evidence

**Verdict: Contradicted.** The specific claim rated here is causal: that acetaminophen taken in pregnancy causes autism. That claim is not supported by the strongest evidence, and the leading medical bodies reject it. Some observational studies did report a statistical association between prenatal acetaminophen use and later autism or ADHD diagnoses, and that association is real in the data; the dispute is over what it means. The best-designed study to date, a 2024 JAMA analysis of about 2.4 million Swedish children that used sibling controls to strip out shared family genetics and environment, found the association vanished once those confounders were removed (autism hazard ratio 0.98). The American College of Obstetricians and Gynecologists (ACOG) reaffirms acetaminophen as the pain and fever reliever of choice in pregnancy and says the weight of evidence does not support a causal link. In September 2025 the Trump administration and HHS Secretary Robert F. Kennedy Jr. announced a warning tying the drug to autism; that policy step, and the medical pushback against it, are reported here as an attributed dispute, not as evidence that the causal claim is true. This file rates the causal claim debunked; it does not tell readers what to take. Follow your clinician's guidance, not a website.

Category: Science, Space & Technology · Era: 2020s · First circulated: Concern built through the 2010s from observational studies, crystallized in a 2021 consensus statement by a group of scientists urging precaution, and reached a mass audience in September 2025 when the U.S. administration publicly linked the drug to autism · Believed by: A causal link is rejected by ACOG, the American Academy of Pediatrics, the Society for Maternal-Fetal Medicine, and, after review, the World Health Organization. The claim gained wide public traction after the September 2025 federal announcement, and remains contested in politics even as the strongest studies and major medical bodies find no established causal effect.
URL: https://theconspiratory.com/theory/acetaminophen-autism-claim

## Summary
For years, a handful of observational studies reported that children whose mothers used acetaminophen (paracetamol, sold as Tylenol) during pregnancy were somewhat more likely to be diagnosed later with autism or ADHD. Those correlations are real in the data, but correlation is not causation, and the reasons a woman takes acetaminophen, fever, infection, pain, chronic conditions with their own genetic loading, can independently affect a child's neurodevelopment. In 2024 a study of roughly 2.4 million Swedish children used a sibling-control design that removes shared family factors, and the apparent association disappeared. In September 2025 President Trump and HHS Secretary Robert F. Kennedy Jr. announced a warning linking the drug to autism, prompting sharp criticism from ACOG, other medical bodies, and the drug's maker. This file separates the documented statistical association from the unsupported causal claim, reports the policy dispute neutrally, and points readers to their clinicians rather than to us.

## The claim
That acetaminophen (Tylenol) taken by a pregnant woman crosses to the fetus and causes or substantially raises the risk of autism, so that the rise in autism diagnoses can be traced in significant part to widespread use of the drug in pregnancy, and that women should therefore avoid it.

## Origin and timeline
- 2019-10: A JAMA Psychiatry study of the Boston Birth Cohort reports that biomarkers of acetaminophen measured in umbilical-cord blood are associated with higher odds of later ADHD and autism diagnoses. It is widely covered and becomes a frequently cited anchor for the concern, though it is observational and cannot establish cause.
- 2021-09: A group of scientists and clinicians publishes a consensus statement in Nature Reviews Endocrinology urging precautionary limits on acetaminophen use in pregnancy, citing accumulated observational associations with neurodevelopmental outcomes. Other researchers respond that the evidence does not justify alarming pregnant patients away from one of the few pain relievers considered safe for them.
- 2023: Reviews and editorials increasingly stress the central methodological problem: women who use acetaminophen in pregnancy differ systematically from those who do not (more fevers, infections, pain, and chronic illness), so a raw association may reflect the reasons for use, a phenomenon called confounding by indication, rather than any effect of the drug.
- 2024-04: JAMA publishes a Swedish nationwide study of about 2.48 million children born 1995-2019 (Ahlqvist and colleagues, Karolinska Institute and Drexel University, NIH-funded). In conventional models a small association appears, but in sibling-control analyses, comparing siblings differently exposed within the same family, the association disappears (autism hazard ratio 0.98). The authors conclude the earlier signals likely reflect familial confounding, not causation.
- 2025-08: The FDA's own acetaminophen information page states the agency has not found clear evidence that appropriate use of the drug in pregnancy causes adverse developmental outcomes, reflecting the mainstream regulatory position going into the autumn.
- 2025-09-22: At a White House event, President Trump and HHS Secretary Robert F. Kennedy Jr. announce actions on autism, including a warning advising against acetaminophen use in pregnancy; the FDA issues a physician notice and begins the process toward a label change. Trump urges pregnant women to 'tough it out.' ACOG, the maker Kenvue, and other medical bodies push back the same day.
- 2025-09: ACOG issues a practice advisory and a news release affirming acetaminophen as the analgesic and antipyretic of choice in pregnancy and stating that the current weight of evidence does not support a causal link to neurodevelopmental disorders. The World Health Organization and the American Academy of Pediatrics issue statements to similar effect.
- 2025-10: The proposed federal messaging is walked back in tone toward describing a possible association rather than a proven cause, and the professional-label proposal frames the relationship as suggestive rather than established. Kenvue formally asks the FDA to reject the labeling petition, arguing the change is unsupported by the science.

## The evidence, claim by claim
- Claim: Multiple studies found that children exposed to acetaminophen in the womb were more likely to be diagnosed with autism.
  Evidence: Several observational studies did report such associations, and that part is not in dispute. The key point is what an association can and cannot show. These studies compare unrelated children and cannot fully separate the drug from the reasons it was taken. An association is a starting point for investigation, not proof of cause, and the strongest later work was designed specifically to test whether this particular association held up.
- Claim: The 2019 cord-blood study measured the drug itself in the baby's blood, so it must show a real biological effect.
  Evidence: Measuring acetaminophen biomarkers in cord blood makes the exposure more precise, which is a genuine strength, but it does nothing to fix confounding: a mother's fever, infection, pain, or underlying genetics can both lead to acetaminophen use and independently affect neurodevelopment. A more accurate exposure measurement in an observational design still cannot establish that the drug, rather than the reason for taking it, is responsible.
- Claim: The association is the same thing as causation, so avoiding the drug will lower autism risk.
  Evidence: This is the central error the strongest study was built to catch. In the 2024 JAMA analysis of about 2.4 million Swedish children, a small association appeared in ordinary models but vanished in sibling comparisons, where one sibling was exposed and another was not within the same family, holding shared genetics and home environment constant. The autism hazard ratio was 0.98, with ADHD and intellectual disability similarly null. That pattern is the signature of confounding, not of a causal drug effect.
- Claim: The reasons a woman takes acetaminophen have nothing to do with her child's neurodevelopment.
  Evidence: The evidence points the other way. Mothers with more genetic liability for autism or ADHD tend to report more pain and are more likely to use acetaminophen, and untreated fever and infection in pregnancy carry their own documented risks. FactCheck.org and researchers note additional problems in some earlier studies, including non-random recruitment of participants already seeking answers about autism. These are exactly the pathways that make a raw correlation misleading.
- Claim: Medical authorities are ignoring the risk and telling women the drug is perfectly safe.
  Evidence: That misstates the guidance. ACOG reaffirms acetaminophen as the preferred option for pain and fever in pregnancy while advising, as it long has, judicious use at the lowest effective dose for the shortest necessary time, in consultation with a clinician. Recommending measured use is not the same as denying a risk; it is the standard framing for any medication in pregnancy, and it reflects a body of evidence that has not established a causal harm.
- Claim: The September 2025 federal warning shows the government has concluded the drug causes autism.
  Evidence: The announcement was a policy and communications action, not a new scientific finding, and it drew immediate criticism from ACOG, the American Academy of Pediatrics, the Society for Maternal-Fetal Medicine, the WHO, and the manufacturer. Within weeks the messaging shifted toward describing a possible association rather than a proven cause. A government statement is reported here as an attributed position in a live dispute; it does not convert an unproven claim into an established fact.
- Claim: If pregnant women simply avoid the drug to be safe, there is no downside.
  Evidence: Clinicians warn there is a real downside. The main risk of the fear message, ACOG and others note, is that pregnant patients may leave a high fever or severe pain untreated, and untreated fever and pain in pregnancy can themselves harm both mother and fetus. 'Just avoid it' is not a neutral default; it trades a hypothetical, unestablished risk for documented ones, which is why the guidance is to decide with a clinician rather than to abstain out of alarm.

## Why people believe it
- The correlation is genuinely there in some studies, and a real statistical signal is far more persuasive than an invented one. It is easy to see why a published association between a common drug and a feared diagnosis lands hard, even though a correlation on its own cannot show cause.
- Autism diagnoses have risen sharply over the same decades that acetaminophen has been the go-to pain reliever in pregnancy, and the mind reaches for a single, tangible cause. A pill a mother took feels more graspable than the messy reality of broadened diagnostic criteria, greater awareness, and many small genetic and environmental contributions.
- The claim offers agency and, sometimes, an answer to guilt or grief. For a parent searching for why, 'a medication caused this' can feel more bearable than 'no single thing did,' and that emotional pull helps the idea travel regardless of what the strongest studies show.
- A high-profile government endorsement gave the claim institutional weight. When a president and a health secretary say it from a podium, many reasonably assume the science must be settled behind them, even when the major medical bodies are saying the opposite.

## Open questions
- Why do raw associations keep appearing at all? The best current answer is confounding by indication (the reasons for taking the drug, from fever to genetics, track with neurodevelopmental outcomes), which is precisely why sibling-controlled designs that hold family factors constant are treated as the more trustworthy test.
- Could very heavy or prolonged use, as opposed to ordinary short-term use, carry any effect? The strongest studies do not establish one, but observational data are always limited at the extremes, and researchers continue to examine dose and duration rather than treating the question as fully closed.
- How did a contested observational signal become a national warning? The 2025 episode is as much about how science is communicated and politicized as about the drug itself, and the gap between the podium and the peer-reviewed literature is part of what this case documents.
- What actually drives the rise in autism diagnoses? The consensus points to expanded diagnostic criteria, increased screening and awareness, and a large, mostly genetic component, not to any single environmental trigger, which is the broader context a one-cause story tends to erase.

## Sources
- Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability, JAMA (Ahlqvist et al.) (2024): https://jamanetwork.com/journals/jama/fullarticle/2817406
- Study reveals no causal link between neurodevelopmental disorders and acetaminophen exposure before birth, National Institutes of Health (2024): https://www.nih.gov/news-events/news-releases/study-reveals-no-causal-link-between-neurodevelopmental-disorders-acetaminophen-exposure-before-birth
- ACOG Affirms Safety and Benefits of Acetaminophen during Pregnancy, American College of Obstetricians and Gynecologists (2025): https://www.acog.org/news/news-releases/2025/09/acog-affirms-safety-benefits-acetaminophen-pregnancy
- Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes, ACOG (Practice Advisory) (2025): https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2025/09/acetaminophen-use-in-pregnancy-and-neurodevelopmental-outcomes
- President Trump, Secretary Kennedy Announce Bold Actions to Tackle Autism Epidemic, U.S. Department of Health and Human Services (2025): https://www.hhs.gov/press-room/hhs-trump-kennedy-autism-initiatives-leucovorin-tylenol-research-2025.html
- Trump Administration's Problematic Claims on Tylenol and Autism, FactCheck.org (2025): https://www.factcheck.org/2025/09/trump-administrations-problematic-claims-on-tylenol-and-autism/
- Trump blames Tylenol for autism. Science doesn't back him up, NPR (2025): https://www.npr.org/sections/shots-health-news/2025/09/22/nx-s1-5550153/trump-rfk-autism-tylenol-leucovorin-pregnancy
- Tylenol's maker pushes back against possible label change linking pain reliever's use in pregnancy to autism, CNN (2025): https://www.cnn.com/2025/10/20/health/tylenol-fda-label-change
- Acetaminophen is Safe for Children When Taken as Directed, No Link to Autism, American Academy of Pediatrics (2025): https://www.aap.org/en/news-room/fact-checked/acetaminophen-is-safe-for-children-when-taken-as-directed-no-link-to-autism/
- WHO statement on autism-related issues, World Health Organization (2025): https://www.who.int/news/item/24-09-2025-who-statement-on-autism-related-issues

Rated by The Conspiratory, a neutral, sourced encyclopedia of conspiracy theories. Full page: https://theconspiratory.com/theory/acetaminophen-autism-claim